Spectrum Pharmaceuticals, Inc. (SPPI) Financial Statements (2024 and earlier)

Company Profile

Business Address 11500 S. EASTERN AVE., SUITE 240
HENDERSON, NV 89052
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

3/31/2023
MRQ
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:75,096100,647180,025223,873203,988227,571
Cash and cash equivalents40,36888,53946,009  227,323
Short-term investments34,72812,108134,01631,04746,422248
Other undisclosed cash, cash equivalents, and short-term investments    192,826157,566 
Receivables12,996 6744129,87332,260
Inventory, net of allowances, customer advances and progress billings9,230   3,5505,715
Inventory9,230   3,5505,715
Prepaid expense  2,2774,16110,1489,57910,067
Other undisclosed current assets3,6891,0282,3949,5583,6982,133
Total current assets:101,011103,952186,647244,020250,688277,746
Noncurrent Assets
Operating lease, right-of-use asset1,6942,5052,2473,806
Property, plant and equipment4764553,57711,607385589
Intangible assets, net (including goodwill)     129,655155,321
Goodwill     18,06118,162
Intangible assets, net (excluding goodwill)     111,594137,159
Other noncurrent assets1574,6364,3274,00010,15853,783
Total noncurrent assets:2,3277,59610,15119,413140,198209,693
TOTAL ASSETS:103,338111,548196,798263,433390,886487,439
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:38,10541,25843,77140,53262,35751,553
Employee-related liabilities11,9719,3757,6869,8539,261
Accounts payable30,54733,40834,38532,01244,91933,648
Accrued liabilities4,580 7688347,5858,644
Other undisclosed accounts payable and accrued liabilities 2,978(4,121)(757)   
Deferred revenue3,082   
Debt    1,683 38,224
Deferred compensation liability      5,100
Deferred revenue and credits3,872
Contract with customer, liability4,850
Other undisclosed current liabilities1,49811,9719,37519,75519,26711,000
Total current liabilities:42,68553,22953,14661,97086,474109,749
Noncurrent Liabilities
Long-term debt and lease obligation28,666     
Long-term debt, excluding current maturities28,666     
Liabilities, other than long-term debt4,09910,7669,40911,0705,6506,530
Deferred revenue and credits315
Other liabilities4,09910,7669,40911,0705,6506,215
Other undisclosed noncurrent liabilities     15,50019,821
Total noncurrent liabilities:32,76510,7669,40911,07021,15026,351
Total liabilities:75,45063,99562,55573,040107,624136,100
Equity
Equity, attributable to parent27,88847,553134,243190,393283,262351,339
Common stock203165146113110100
Additional paid in capital1,149,9261,094,3531,021,221918,205886,740837,347
Accumulated other comprehensive income (loss)(2,917)(3,042)(1,829)(3,498)(3,702)15,999
Accumulated deficit(1,119,324)(1,043,923)(885,295)(724,427)(599,886)(502,107)
Total equity:27,88847,553134,243190,393283,262351,339
TOTAL LIABILITIES AND EQUITY:103,338111,548196,798263,433390,886487,439

Income Statement (P&L) ($ in thousands)

3/31/2023
TTM
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Revenues10,1145,7221,408 109,333128,367
Revenue, net128,367
Gain (loss) on disposition of assets for financial service operations(1,346)5,7221,408(12,665) 
Cost of revenue(1,792)  (12)(18,561)(39,099)
Cost of goods and services sold(1,792)    (32,006)
Other undisclosed gross profit      
Gross profit:8,3225,7221,408(12)90,77289,268
Operating expenses(81,019)(147,703)(169,734)(140,686)(221,949)(185,928)
Other undisclosed operating loss  (5,722)(1,408)   
Operating loss:(72,697)(147,703)(169,734)(140,698)(131,177)(96,660)
Nonoperating income (expense)(5,361)(10,729)(1,598)(3,896)11,167(11,366)
Other nonoperating income (expense)(5,331)(10,892)(2,940)(8,892)9,580389
Interest and debt expense     (3,132)(8,072)
Loss from continuing operations before equity method investments, income taxes:(78,058)(158,432)(171,332)(144,594)(123,142)(116,098)
Other undisclosed income from continuing operations before income taxes     3,1328,072
Loss from continuing operations before income taxes:(78,058)(158,432)(171,332)(144,594)(120,010)(108,026)
Income tax expense (benefit)(46)(4)609,208(1)16,778
Loss from continuing operations:(78,104)(158,436)(171,272)(135,386)(120,011)(91,248)
Loss before gain (loss) on sale of properties:(158,436)(171,272)(135,386)(120,011)(91,248)
Net loss:(78,104)(158,436)(171,272)(135,386)(120,011)(91,248)
Other undisclosed net income (loss) attributable to parent2,703(192)10,40422,697  
Net loss available to common stockholders, diluted:(75,401)(158,628)(160,868)(112,689)(120,011)(91,248)

Comprehensive Income ($ in thousands)

3/31/2023
TTM
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Net loss:(78,104)(158,436)(171,272)(135,386)(120,011)(91,248)
Other comprehensive loss      
Other undisclosed comprehensive loss      
Comprehensive loss:(78,104)(158,436)(171,272)(135,386)(120,011)(91,248)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent2,828(1,405)12,07322,901(2,490)17,578
Comprehensive loss, net of tax, attributable to parent:(75,276)(159,841)(159,199)(112,485)(122,501)(73,670)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: